Sanctuary Advisors, LLC Verve Therapeutics, Inc. Transaction History
Sanctuary Advisors, LLC
- $15.5 Trillion
- Q3 2025
A detailed history of Sanctuary Advisors, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 11,665 shares of VERV stock, worth $129,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,665
Previous 11,665
-0.0%
Holding current value
$129,831
Previous $131 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VERV
# of Institutions
20Shares Held
8.52MCall Options Held
2.9KPut Options Held
37.1K-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL1.32MShares$14.6 Million0.0% of portfolio
-
Wade G W & Inc Wellesley, MA260KShares$2.89 Million0.12% of portfolio
-
Xtx Topco LTD London, X0125KShares$1.39 Million0.08% of portfolio
-
Credit Suisse Ag Zurich, V865.7KShares$731,7080.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...